Exelixis Inc. (EXEL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Exelixis Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Exelixis Inc. (EXEL) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $16.2B. It trades at $66.28, up 1.42% today, at 19.1 times earnings. Its overall quality score is 83 out of 100, ranked against the whole US market. 13 analysts' average target of $53.45 implies −19.4% from today's price. Kronos AI's 30-day forecast is −19.3% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $53.45 |
| Low – high | $41.00 – $65.00 |
| Analysts | 13 |
| Upside to average | −19.4% |
Kronos AI 30-day forecast
| Expected close | $52.75 (−19.3%) |
| Likely range | −21.2% … −16.5% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 92 |
| Solvency | 80 |
| Growth | 78 |
| Overall | 83 |
| P/E | 19.1 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator